GSK’s follow-up to its severe asthma therapy Nucala has shown its value in a pair of phase 3 trials, reducing exacerbations compared to placebo with dosing once every six months. The company says new ...

Phase II trials are conducted to provide evidence of the effectiveness of a therapeutic intervention in patients and to determine the optimal treatment regimen (for example, dosing schedule) for ...